This trial has never been done on humans, but it has been studied in animals with encouraging results.
- Hypoxic-Ischemic Encephalopathy
3 Primary · 4 Secondary · Reporting Duration: 18-24 months
Awards & Highlights
2 Treatment Groups
Control Arm - No Remote Ischemic Conditioning
1 of 2
Intervention Arm - Remote Ischemic Conditioning
1 of 2
32 Total Participants · 2 Treatment Groups
Primary Treatment: Remote Ischemic Conditioning · No Placebo Group · N/A
Who is running the clinical trial?
Age Any Age · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are taking part in this trial?
"Affirmative. Per the information released on clinicaltrials.gov, this research trial is in current need of subjects. The study was initially posted on January 17th 2022 and was most recently modified on October 18th 2022. 32 volunteers are being recruited from 1 location for participation in the experiment." - Anonymous Online Contributor
What is the desired outcome of this research project?
"During this 72 hour clinical trial, the primary assessment will be centered around gauging the feasibility of this study. Secondary objectives include observing any transient and persistent pain via PIPP score > 7 as well as monitoring for cutaneous injury within 24 hours after completion of the maneuver compared to baseline assessments. Lastly, a patient's status regarding transient/persistent pain shall also be determined based on their respective PIPP scores over 6 hour intervals post-maneuver." - Anonymous Online Contributor
What is the current status of this research endeavor with regard to patient enrollment?
"Affirmative. Clinicaltrials.gov reports that the recruitment process for this trial, which was first posted on January 17th 2022, is ongoing with 32 participants being accepted at a single site." - Anonymous Online Contributor